TRANSPLANT home | Faculty listing

UT Transplant Center Faculty

Kermit V Speeg, MD, PhD

Professor of Medicine
Medical Director, Adult Liver Transplantation

Photo - Dr. Speeg Email:

Board Certifications:
Diplomat, National Board of Medical Examiners
American Board of Internal Medicine

MD, University of Texas Southwestern Medical School at Dallas, 1972
PhD, Rice University, 1968
MA, Rice University, 1966
BA, Rice University, 1965

Postgraduate training:
GI/Hepatology Fellowship, Vanderbilt University Affiliated Hospitals, 1976-1978
Research Associate, National Cancer Institute, National Institutes of Health, 1974-1976
Medicine Residency, Vanderbilt University Affilitated Hospitals, 1972-1974

Research interests: all aspects of liver disease, drug metabolism, drug toxicities, drug secretion at the bile canaliculus and renal tubule.

Clinical interests: liver disease, drug metabolism and drug-drug interactions

Washburn WK, Pollock BH, Nichols L, Speeg KV, Halff GA. Impact of Recipient MELD score on Resource Utilization. American J Transplantation 2006; 6:2449-2454.

Washburn K, Speeg V, Esterl R, Cigarroa F, Pollack M, Tourtellot C, Maxwell P, Halff G. Steroid Elimination 24 hours after Liver Transplantation using Daclizumab, Tacrolimus, and Mycophenolate mofetil. Transplantation, 72:1675-1679, 2001.

Mejia A, Halff GA, Esterl R, Cigarroa F, Speeg KV, Villarreal R, Washburn K. Outcome of liver transplantation in Hispanics versus non-Hispanic: is there a difference? Transplantation Proceedings 34:1236-1238, 2002.

Postoak DW, Ferral H, Washburn WK, Speeg KV, Wholey MH. Transjugular Intrahepatic Portosystemic Shunt Creation in a Patient with Situs Inversus (Letter). J Vasc Intervent Radiology. 13(7):755-756, 2002.

Ferral H, Vasan, R, Speeg KV, Serna S, Young C, Postoak DW, Wholey MH, McMahan CA. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Intervent Radiology. 2002; 13:1103-1108.

Lovell MO, Speeg KV, Havranek RD and Sharkey FE. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine. Human Pathology 2003; 34:187-189.

Baughman SM, Speeg, KV. Practical Pearls in Surgery: Use of Orthopedic Traction Device for Sengstaken-Blakemore Counter-Traction. Contemporary Surgery 2003, 59:378.

Rettally CA and Speeg KV. Infection with Listeria monocytogenes following orthotopic liver transplantation: case report and review of the literature. Liver Transplantion Proceedings 35:1485-1487, 2003.

Lovell MO, Speeg KV, Halff GA, Molina DK and Sharkey, FE. Acute hepatic allograft rejection: a comparison of patients with and without centrolobular alterations during first rejection episode. Liver Transplantation 10:369-373, 2004

Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV and McMahan CA. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 231:231-236, 2004.

Pollack MS, Speeg KV, Callander NM, Freytes CO, Esterl RM, Abrahamian GA, Washburn WK, Halff GA. Severe, Late-onset Graft vs. Host Disease in a Liver Transplant Recipient Documented by Chimerism Analysis Human Immunology 66:28-31, 2005.

Biosketch: Dr. Speeg completed graduate school (MA, PhD) at Rice University studying comparative biochemistry and physiology. The received his medical degree from the University of Texas Southwestern Medical School in Dallas. He completed a medicine residency in Nashville, Tennessee at the Vanderbilt University Affiliated Hospitals. He was a Research Associate in the US Public Health Service at the National Cancer Institute in Bethesda, MD for two years before going back to Vanderbilt to complete GI fellowship. He was a member of the GI faculty of the Vanderbilt Medical School from 1977 until 1982. At that time he moved to San Antonio and the GI Division of the UTHSC-San Antonio and the Audie Murphy VA Medical Center. He has transitioned from primarily bench research to clinical care during the last 10 years. He has been the transplant hepatologist for the UHS/UTHSC adult liver transplant program since its beginning.

Professional Societies:
Sigma Xi, American Physiological Society, American Association for the Study of Liver Disease, Texas Transplantation Society